← Eichor
Study identifier: NCT03392233 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Stereotactic Body Radiation Therapy for Spinal Metastases in Favorite Tumors

Condition: Breast Cancer · Prostate Cancer · Non Small Cell Lung Cancer  ·  Sponsor: RenJi Hospital

PhasePhase 2
Planned participants100
Who can joinAll sexes, 18 Years to 85 Years
Healthy volunteersNo

About this study

Stereotactic Body Radiation Therapy(SBRT) for spinal metastases has been proved a good results in pain relieve and local control, However,the longterm of efficacy and safety of this regimen is unclear.The purpose of the study is to evaluate the longterm outcome of this therapeutic regimen in selective patients who will be survival more than 2 years.

This description comes directly from the study's public registry record.

Talk to the study team

Ming Ye, Master  ·  +862168383459  ·  renjiyeming@163.com

Qi Lu, Master  ·  +8621-58752345  ·  luqi@renji.com

Always discuss trial participation with your own doctor first.

Locations (1)

Department of Radiation Oncology,Renji Hospital affiliated to Shanghai Jiaotong University School of MedicineShanghai, Shanghai Municipality, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT03392233